Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
Author:
Publisher
Frontiers Media SA
Subject
General Medicine
Reference90 articles.
1. Global Initiative for the Management of Asthma 20152016
2. T-helper type 2-driven inflammation defines major subphenotypes of asthma;Woodruff;Am J Respir Crit Care Med,2009
3. Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?;De Ferrari;Expert Rev Respir Med,2016
4. Severe asthma: from characteristics to phenotypes to endotypes;Wenzel;Clin Exp Allergy,2012
5. Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program;Fitzpatrick;J Allergy Clin Immunol,2011
Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insight into IL-5 as a Potential Target for the Treatment of Allergic Diseases;Biomedicines;2024-07-10
2. Role of IL‐5 in asthma and airway remodelling;Clinical & Experimental Allergy;2024-06-27
3. Navigating biologic therapies in elderly asthma;Respiratory Medicine;2024-06
4. Epithelial IL5RA promotes epithelial-mesenchymal transition in pulmonary fibrosis via Jak2/STAT3 cascade;Pulmonary Pharmacology & Therapeutics;2024-03
5. Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update;American Journal of Clinical Dermatology;2023-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3